Department of Epidemiology and Health Statistics, Shandong University, Jinan, 250012 Shandong, People's Republic of China.
Diabetologia. 2011 Apr;54(4):803-11. doi: 10.1007/s00125-010-2004-5. Epub 2010 Dec 22.
AIMS/HYPOTHESIS: A meta-analysis was performed to assess the association of C47T (rs4880) (also called Val16Ala) polymorphism in SOD2 gene with reduced risk of diabetes mellitus, including type 1 and type 2 diabetes, and diabetic microvascular complications (DMI) including diabetic nephropathy, diabetic retinopathy and diabetic polyneuropathy.
A comprehensive search was conducted to identify all case-control or cohort design studies of the above-mentioned associations. The fixed or random effect pooled measure was selected on the basis of homogeneity test among studies. Heterogeneity among studies was evaluated using the I (2). Meta-regression and the 'leave one out' sensitive analysis of Patsopoulos et al. were used to explore potential sources of between-study heterogeneity. Publication bias was estimated using modified Egger's linear regression test as proposed by Harbord et al.
Seventeen articles were included. After excluding articles that deviated from Hardy-Weinberg equilibrium in cases and/or in controls, and were also the key contributors to between-study heterogeneity, the meta-analysis showed a significant association of the C allele with reduced risk of DMI in dominant (OR 0.788, 95% CI 0.680-0.914), recessive (OR 0.808, 95% CI 0.685-0.953) and codominant (OR 0.828, 95% CI 0.751-0.913) models. It also showed a significant association with reduced risk of diabetic nephropathy in the dominant model (OR 0.801, 95% CI 0.664-0.967), and reduced risk of diabetic retinopathy in the dominant (OR 0.601, 95% CI 0.423-0.855), recessive (OR 0.548, 95% CI 0.369-0.814) and codominant (OR 0.651, 95% CI 0.517-0.820) models.
CONCLUSIONS/INTERPRETATION: The meta-analysis suggested that C allele of C47T polymorphism in SOD2 gene has protective effects on risk of DMI, diabetic nephropathy and diabetic retinopathy. This risk needs to be confirmed by further studies.
目的/假设:进行了一项荟萃分析,以评估 SOD2 基因中的 C47T(rs4880)(也称为 Val16Ala)多态性与糖尿病(包括 1 型和 2 型糖尿病)以及糖尿病微血管并发症(DMI)(包括糖尿病肾病、糖尿病视网膜病变和糖尿病多发性神经病)风险降低之间的关联。
进行了全面的搜索,以确定所有上述关联的病例对照或队列设计研究。根据研究之间的同质性检验,选择固定或随机效应合并度量。使用 I(2)评估研究之间的异质性。使用 Patsopoulos 等人的“排除一个”敏感分析和荟萃回归来探索研究之间异质性的潜在来源。使用 Harbord 等人提出的修改后的 Egger 线性回归检验估计发表偏倚。
纳入了 17 篇文章。在排除了病例和/或对照中偏离 Hardy-Weinberg 平衡且也是研究之间异质性主要贡献者的文章后,荟萃分析显示 C 等位基因与显性(OR 0.788,95%CI 0.680-0.914)、隐性(OR 0.808,95%CI 0.685-0.953)和共显性(OR 0.828,95%CI 0.751-0.913)模型中 DMI 风险降低显著相关。它还显示出与显性模型中糖尿病肾病风险降低(OR 0.801,95%CI 0.664-0.967)以及显性(OR 0.601,95%CI 0.423-0.855)、隐性(OR 0.548,95%CI 0.369-0.814)和共显性(OR 0.651,95%CI 0.517-0.820)模型中糖尿病视网膜病变风险降低显著相关。
结论/解释:荟萃分析表明,SOD2 基因中的 C47T 多态性的 C 等位基因对 DMI、糖尿病肾病和糖尿病视网膜病变的风险具有保护作用。这一风险需要通过进一步的研究来证实。